Skip to content

Important changes to S8 medicines approval requirements

The HealthPathways Schedule 8 (S8) medicines page has been updated to reflect important changes in S8 NSW Health approval requirements.

The HealthPathways Schedule 8 (S8) medicines page has been updated to reflect important changes in S8 NSW Health approval requirements. These changes commenced on the 5 November 2026 and have occurred due to implementation of a new Medicines, Poisons and Therapeutics Goods Act and Regulation in NSW.

Key changes for GP prescribers include:

  • Removal of the requirement to include the NSW Health approval number on prescriptions for Schedule 8 psychostimulant medicines (dexamfetamine, methylphenidate, lisdexamfetamine)
  • Changes to the circumstances in which a prescriber must seek approval to prescribe from NSW Health and expanded exemptions from approval requirements
  • Changes to the definition of substance-dependence when determining the need for an approval. Substance-dependence is now defined per ICD-11 or DSM-5
  • New standards for prescribing medicines under the Opioid Treatment Program
  • New approval forms and requirements for supplementary information.
  • self-prescribing of Schedule 8 and Schedule 4D medicines is no longer permitted

The updated Schedule 8 Medicines HealthPathway includes key information for use in a consult including referral navigation advice to support approval applications and additional requirements for PBS prescriptions as well as S8 medicine storage and destruction.

Related articles


Related category


Get news in your inbox

Subscribe to the HNC newsletter for the latest news, events and updates from the North Coast.

Join

We use cookies to improve your experience and analyse site usage.

By using this site you agree to our use of cookies. You can manage your preferences at any time.